Benralizumab-induced interstitial granulomatous dermatitis: a case report

Elsevier

Available online 27 September 2022

TherapiesKeywords

Interstitial granulomatous dermatitis

Severe asthma

Benralizumab

Monoclonal antibody

Anti-IL5 receptor

View full text

© 2022 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

留言 (0)

沒有登入
gif